Related references
Note: Only part of the references are listed.Identification of a neo-epitope dominating endogenous CD8 T cell responses to MC-38 colorectal cancer
Brett J. Hos et al.
ONCOIMMUNOLOGY (2020)
Assessment of the expression of the immune checkpoint molecules PD-1, CTLA4, TIM-3 and LAG-3 across different cancers in relation to treatment response, tumor-infiltrating immune cells and survival
Lei Tu et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Ferritin nanoparticle-based SpyTag/SpyCatcher-enabled click vaccine for tumor immunotherapy
Wenjun Wang et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2019)
Anti-tumor immunity induced by ectopic expression of viral antigens is transient and limited by immune escape
Neeraja Dharmaraj et al.
ONCOIMMUNOLOGY (2019)
A Tumor-Peptide-Based Nanoparticle Vaccine Elicits Efficient Tumor Growth Control in Antitumor Immunotherapy
Carolin Hesse et al.
MOLECULAR CANCER THERAPEUTICS (2019)
A multipeptide vaccine plus toll-like receptor agonists LPS or polylCLC in combination with incomplete Freund's adjuvant in melanoma patients
Marit M. Melssen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
PD-1 and LAG-3 Dominate Checkpoint Receptor-Mediated T-cell Inhibition in Renal Cell Carcinoma
Henning Zelba et al.
CANCER IMMUNOLOGY RESEARCH (2019)
The adjuvant effect of melanin is superior to Incomplete Freund adjuvant in a tumor subunit vaccine model
A. F. Carpentier et al.
EUROPEAN JOURNAL OF CANCER (2018)
Personalized vaccines for cancer immunotherapy
Ugur Sahin et al.
SCIENCE (2018)
LAG3 (CD223) as a cancer immunotherapy target
Lawrence P. Andrews et al.
IMMUNOLOGICAL REVIEWS (2017)
Synthetic melanin bound to subunit vaccine antigens significantly enhances CD8+ T-cell responses
Antoine F. Carpentier et al.
PLOS ONE (2017)
Peptide vaccines in cancer - old concept revisited
Takumi Kumai et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
A Therapeutic Her2/neu Vaccine Targeting Dendritic Cells Preferentially Inhibits the Growth of Low Her2/neu-Expressing Tumor in HLA-A2 Transgenic Mice
Thi Tran et al.
CLINICAL CANCER RESEARCH (2016)
CpG-mediated augmentation of CD8+ T-cell responses in mice is attenuated by a water-in-oil emulsion (Montanide ISA-51) but enhanced by an oil-in-water emulsion (IDRI SE)
Shawn R. Makinen et al.
INTERNATIONAL IMMUNOLOGY (2016)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
Vaccines, Adjuvants, and Dendritic Cell Activators-Current Status and Future Challenges
Joseph Obeid et al.
SEMINARS IN ONCOLOGY (2015)
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
Mahesh Yadav et al.
NATURE (2014)
Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion
Yared Hailemichael et al.
NATURE MEDICINE (2013)
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
Hirokazu Matsushita et al.
NATURE (2012)
Pitfalls of vaccinations with WT1-, Proteinase3-and MUC1-derived peptides in combination with MontanideISA51 and CpG7909
Juergen Kuball et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Type I IFNs Control Antigen Retention and Survival of CD8α+ Dendritic Cells after Uptake of Tumor Apoptotic Cells Leading to Cross-Priming
Silvia Lorenzi et al.
JOURNAL OF IMMUNOLOGY (2011)
Adjuvant Properties of Cytosine-Phosphate-Guanosine Oligodeoxynucleotide in Combination with Various Polycations in an Ovalbumin-Vaccine Model
Sylvie Maubant et al.
NUCLEIC ACID THERAPEUTICS (2011)
Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study
Alexandre Carpentier et al.
NEURO-ONCOLOGY (2010)
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Martin F. Bachmann et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
CD8+ CTL priming by exact peptide epitopes in incomplete Freund's adjuvant induces a vanishing CTL response, whereas long peptides induce sustained CTL reactivity
Martijn S. Bijker et al.
JOURNAL OF IMMUNOLOGY (2007)
Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming
Danila Valmori et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Constant rate of steady-state self-antigen trafficking from skin to regional lymph nodes
Miya Yoshino et al.
INTERNATIONAL IMMUNOLOGY (2006)
Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN
CL Ahonen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Skin antigens in the steady state are trafficked to regional lymph nodes by transforming growth factor-β1-dependent cells
H Hemmi et al.
INTERNATIONAL IMMUNOLOGY (2001)
Share Paper
